Company Background

EndoCross is a privately held medical device company founded in 2006.

Our team of experienced physicians and engineers specialize in developing and bringing to market innovative, cost effective and easy to use medical devices for the cardiovascular arena. At EndoCross we are devoted to developing and bringing to market first line solutions to treat challenging lesions including Chronic Total Occlusions (CTOs).

Our first product, the ENABLER-P Catheter System, is CE marked and designed for use in the peripheral vasculature including both the above the knee and below the knee vessels. We are now introducing our ENABLER-C Catheter System for use in the Coronary environments.

Headquartered in the medical device hub of Yokneam, Israel, EndoCross works with top-tier US and European physicians and advisors to ensure Intellectual Property (IP), legal and regulatory compliance.

EndoCross technology is covered by several patent families, the first patent having been granted by the EU in 2010.